What Are The Clinical Characteristics Of Actinic Keratosis (Ak), And What Safety Screening Is Required Before Using Fractional Lasers Or Microneedle Rf? Ensure Safe Resurfacing With Proper Lesion Evaluation

Actinic keratosis (AK) is a sun-related precancerous keratinocytic lesion that requires clinical caution before cosmetic resurfacing. It typically appears as a rough, adherent, pink-to-red or skin-colored patch or papule, often about 3–6 mm, on chronically sun-exposed skin. Before fractional CO₂/Erbium lasers or microneedle RF, clinicians must inspect the treatment area for AK and other suspicious lesions, avoid treating abnormal skin, and refer lesions with concerning features for dermatologic assessment.

Do not use fractional lasers or microneedle RF over a lesion that may be AK or invasive squamous cell carcinoma. Confirm that suspicious, inflamed, bleeding, oozing, rapidly changing, or thickened lesions have been medically evaluated before proceeding.

Recognizing the Clinical Characteristics of AK

Typical appearance

AK commonly presents as a rough or sandpaper-like patch that may be easier to feel than to see. Color ranges from pink or red to skin-colored or brown, and the lesion may have a sharply adherent scale.

Individual lesions are often small, commonly around 3–6 mm, but they may enlarge, become thicker, or occur as multiple lesions within a sun-damaged field.

Common locations

AK most often develops on chronically sun-exposed areas, including the:

Face and forehead
Scalp, particularly in people with hair loss
Ears
Dorsal hands and forearms
Neck and chest

Symptoms and changes

Some AKs are asymptomatic, while others cause roughness, tenderness, itching, burning, or sensitivity. A scale may bleed if forcibly picked, but spontaneous bleeding, ulceration, persistent oozing, or marked tenderness requires greater concern.

A lesion that becomes thicker, more inflamed, rapidly enlarges, or develops an indurated base may represent progression toward invasive cutaneous squamous cell carcinoma (SCC) rather than uncomplicated AK.

Risk factors

Risk increases with:

Chronic ultraviolet exposure
Fair or lighter skin tones and a tendency to sunburn
Older age and cumulative photodamage
Immunosuppression, including transplant-related or medication-related immunosuppression
Previous AKs or skin cancers

AK is not itself invasive SCC and is not accurately described as an SCC confined to the epidermis. It is a precancerous lesion with atypical keratinocytes that can progress to SCC, while SCC in situ is a more advanced, distinct intraepidermal malignancy.

Required Screening Before Fractional Laser or Microneedle RF

Inspect the entire proposed treatment field

Screen the treatment area under adequate lighting and palpate suspicious regions when appropriate. Look for rough scaly patches, persistent redness, crusting, ulceration, bleeding, induration, or lesions that differ from the surrounding photodamaged skin.

A professional skin-analysis system can help identify subtle erythema, scaling, and photodamage, but it does not replace clinical examination or biopsy when malignancy is suspected.

Exclude untreated AK and suspicious lesions

Do not perform fractional laser or microneedle RF directly over:

Known untreated AK
A lesion with changing scale or increasing thickness
Spontaneous bleeding, ulceration, or oozing
Rapid growth or persistent inflammation
Significant tenderness or an indurated base
Any lesion clinically suspicious for SCC or another skin cancer

The correct next step is dermatologic evaluation, with biopsy or treatment when clinically indicated. Cosmetic treatment should be delayed until the lesion has been assessed and the treatment plan is medically appropriate.

Review relevant medical history

The pre-treatment consultation should include a history of:

Previous AK, SCC, melanoma, or other skin cancer
Immunosuppression or immune-modifying medication
Abnormal or prolonged wound healing
Keloid or hypertrophic scar formation
Active infection, herpes reactivation, or dermatitis
Recent tanning or significant sun exposure
Medications and conditions that may increase bleeding, photosensitivity, or healing complications

The exact medication restrictions depend on the device, treatment depth, and clinical protocol. A device-specific checklist and medical assessment should guide final eligibility.

Screen for active inflammatory disease

Do not treat through active inflammatory dermatoses, including an unstable psoriasis flare. Mechanical punctures from microneedle RF and thermal or ablative injury from fractional lasers can trigger Koebnerization, in which new psoriatic lesions develop at sites of trauma.

Look for active erythema, papules around established plaques, scaling, or rapidly changing lesion borders. Treatment should generally wait until the condition is clinically stable.

Assess skin type and treatment risk

Document baseline pigmentation, recent sun exposure, and the patient’s tendency toward post-inflammatory hyperpigmentation or hypopigmentation. Darker skin tones and recently tanned skin may carry a higher risk of pigmentary complications, particularly with more aggressive fractional laser settings.

Microneedle RF may offer a lower epidermal pigment injury risk than ablative fractional laser in some patients, but it is still a controlled skin injury and is not automatically safe over suspicious or inflamed lesions.

Why Cosmetic Treatment Must Be Delayed

Energy devices can obscure clinical changes

Ablative and thermal treatments can produce erythema, crusting, swelling, and delayed healing. These expected reactions may obscure the appearance of an untreated AK or make it harder to recognize progression.

Treatment does not substitute for cancer management

Fractional laser and microneedle RF are cosmetic or scar-remodeling procedures. They should not be used to “resurface” a lesion that may require cryotherapy, field treatment, excision, curettage, or biopsy-directed management.

The treatment field can include more than one problem

Sun-damaged skin may contain visible AKs as well as subtle lesions that are difficult to identify without careful examination. Treating the surrounding field without first addressing suspicious lesions can delay diagnosis.

Understanding the Trade-offs

Fractional laser versus microneedle RF

Fractional CO₂ and Erbium lasers create controlled thermal injury, with CO₂ generally providing stronger ablation and more substantial remodeling for deep or complex atrophic scars. They also tend to involve more downtime and a greater risk of inflammation and pigmentary change.

Microneedle RF delivers energy through mechanical needles and localized thermal injury. It may be selected when the goal is lower surface disruption, faster recovery, or reduced pigmentary risk, but it still requires intact, non-inflamed, medically cleared skin.

Screening tools have limitations

Visual inspection and imaging can identify warning signs, but neither reliably excludes malignancy in every case. Biopsy remains the definitive diagnostic method when clinical findings are uncertain or concerning.

“Small” does not mean safe to treat

A small lesion can still be clinically significant. Size alone should never override features such as induration, spontaneous bleeding, ulceration, rapid change, or persistent tenderness.

Making the Right Choice for Your Goal

A safe protocol should combine lesion recognition, medical history, skin assessment, and clear referral criteria.

If your primary focus is identifying AK: Look for persistent rough, adherent scaly patches or papules on sun-exposed skin, particularly in patients with substantial sun exposure, lighter skin, or immunosuppression.
If your primary focus is treatment safety: Do not perform fractional laser or microneedle RF over untreated AK, suspicious lesions, active infection, or active inflammatory disease.
If your primary focus is ruling out SCC: Refer lesions with increasing thickness, induration, rapid growth, spontaneous bleeding, ulceration, oozing, or significant tenderness to a dermatologist.
If your primary focus is selecting a device: Consider scar depth, downtime, skin type, pigmentary risk, and recovery goals only after the treatment field has been medically cleared.

The safest approach is to diagnose or refer abnormal lesions first and perform cosmetic resurfacing only on stable, clinically appropriate skin.

Summary Table:

Feature	Clinical Characteristics
Appearance	Rough, sandpaper-like patch; pink, red, skin-colored, or brown; may have adherent scale
Size	Usually 3-6 mm, can be larger or multiple
Location	Sun-exposed areas: face, scalp, ears, hands, forearms, neck, chest
Symptoms	Often asymptomatic; may cause roughness, tenderness, itching, burning
Warning Signs	Spontaneous bleeding, ulceration, oozing, induration, rapid growth, significant tenderness
Risk Factors	Chronic UV exposure, fair skin, older age, immunosuppression, history of skin cancer
Screening Before Laser/RF	Full-field inspection, palpation, exclude AK/suspicious lesions, review medical history, assess skin type, avoid active inflammation

Ready to enhance your practice with advanced aesthetic devices? At BELIS, we provide professional-grade medical aesthetic equipment trusted by clinics and premium salons worldwide. Our cutting-edge portfolio includes fractional lasers, microneedle RF, and more—all designed to deliver safe, effective treatments when used by trained professionals. Partner with us to access the latest technology, comprehensive training, and dedicated support. Contact our team today to explore how BELIS can elevate your services and grow your business. Contact us now to discuss your needs!